Author: admin_7b3Rwhh

Paul Nicholls, from Essex, says the tournament gave hope to people living with the disease.

Paul Nicholls, from Essex, says the tournament gave hope to people living with the disease.

By Carey Gillam The Environmental Protection Agency (EPA) is moving to withdraw its interim regulatory decision on paraquat, announcing that it needs more time to examine the potential health effects of the weed killing chemical that has been widely used in agriculture for decades, but also linked for years to the incurable brain ailment known as Parkinson’s disease. The EPA had promised to issue a report by Friday, January 17 updating its position on paraquat after a petition filed by the Michael J. Fox Foundation for Parkinson’s Research and several other health advocacy organizations challenged the EPA’s 2021 interim registration review decision in which the agency concluded that there was “insufficient” evidence linking paraquat exposure to Parkinson’s. That interim EPA decision did call for certain mitigation measures to reduce risks the agency said it found necessary to protect human health and the environment, and labels on paraquat products were amended in 2022 to reflect those measures. But critics have pressed the EPA to go further and ban the chemical entirely. The petition, filed in the 9th US Circuit Court of Appeals, challenged not only the agency’s position on Parkinson’s risk, but also the EPA’s analysis of respiratory and dermal exposures, exposure risks from paraquat drift, and how to balance paraquat’s risks and benefits. As part of the process of reexamining its interim decision, the agency said a year ago that it would spend 2024 analyzing new information about paraquat health effects and taking public comments about the issue under consideration. The agency said last year it would issue a final document and potential next steps for paraquat use by the mid-January 2025 date. Instead, on Friday, the EPA said it is delaying any action. The agency issued a statement saying it had “determined that additional data are necessary to resolve the uncertainty” surrounding certain paraquat risks. The agency cited the “potential for paraquat to volatize,” and said it would be trying to determine potential “inhalation risks to bystanders from the volatilization of paraquat.” Such data “could change the underlying human health risk assessment,” and the regulatory decision based on that assessment, the EPA said. And on Friday, the EPA asked the 9th Circuit to allow it to withdraw its interim decision on paraquat while it further investigates the concerns surrounding the chemical. “EPA intends to withdraw the Interim Decision and will promptly do so once the Court rules on this motion,” the agency states in its court filing. If the court agrees, the case brought by the health advocacy groups will become moot, the EPA argues in the filing.

Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by 57% for every 10-decibel decline in hearing, though a direct causal link remains unclear. This finding suggests that managing hearing impairment could benefit Parkinson’s diagnosis and care. Rese

Dance is therapy — whether it is to cure a medical condition or heal the soul, it has been known to help.

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction. Its pathological hallmark is the abnormal aggregation of α-synuclein (α-syn) …

Experts share early symptoms of Parkinson’s disease and how they vary for women. Plus get advice on managing the condition and improving quality of life.

This is the future.

A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s disease.

Since the series began in 2019, the free events have been designed to empower people with Parkinson’s and care partners to better manage the disease, learn…